Related Experiment Video

Updated: Jun 28, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

[Viral loads in pediatric HIV patients with antiretroviral treatment]

Leticia Porto-Espinoza1, Reyna Moronta, César Cuadra-Sánchez

  • 1Laboratorio Regional de Referencia Virológica, Instituto de Investigaciones Clínicas, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela. letiporto@yahoo.com

Revista Medica De Chile
|October 25, 2008
PubMed

Insights

Viral load monitoring in children with HIV on antiretroviral treatment showed a decrease in viral load and an increase in CD4/CD8 counts over three years. This method aids in assessing treatment response and predicting disease progression.

Area of Science:

  • Pediatric Infectious Diseases
  • Virology
  • Immunology

Context:

  • Human Immunodeficiency Virus (HIV) infection in children requires ongoing monitoring.
  • Antiretroviral therapy (ART) is crucial for managing pediatric HIV.
  • Viral load quantification is essential for therapeutic decision-making.

Purpose:

  • To evaluate the effectiveness of viral load monitoring in pediatric HIV patients undergoing ART.
  • To assess changes in viral load and lymphocyte subpopulations over time.
  • To determine the utility of viral load as a prognostic and therapeutic assessment tool.

Summary:

  • Fifty pediatric patients (1-12 years) with HIV were monitored for viral load every six months over three years using the AMPLICOR HIV-1 Monitor assay.
  • Results indicated a decrease in viral load and an increase in CD4 and CD8 lymphocyte counts.
  • No significant correlation was found between lymphocyte subpopulation counts and viral load levels.

Impact:

  • Viral load measurement is confirmed as an effective method for quantifying plasma HIV-RNA.
  • This quantification aids in defining patient status, predicting clinical outcomes, and evaluating ART efficacy.
  • Regular viral load monitoring supports personalized treatment strategies in pediatric HIV management.
Abstract

More Related Videos

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays13:58

Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays

Published on: September 26, 2011

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...